Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  2,553 نتائج ل ""CTLA-4 Antigen""

فلترة النتائج

إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Combination of transcriptome and Mendelian inheritance reveals novel prognostic biomarker of CTLA-4-related lncRNAs and protective role of nitrogen metabolism pathway in lung adenocarcinoma development.

  • Authors : Shan H; Department of Clinical Laboratory, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, China.; Department of Radiation Oncology, Guangdong Second People's Hospital, Jinan University, Guangzhou, China.

Subjects: RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics ; CTLA-4 Antigen*/CTLA-4 Antigen*/CTLA-4 Antigen*/genetics ; CTLA-4 Antigen*/CTLA-4 Antigen*/CTLA-4 Antigen*/metabolism

  • Source: BMC cancer [BMC Cancer] 2024 Aug 14; Vol. 24 (1), pp. 1009. Date of Electronic Publication: 2024 Aug 14.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy.

  • Authors : Su X; The First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Lanzhou, 730000, China.; Department of General Surgery, Gansu Provincial Hospital, No. 204 Donggang West Road, Chengguan District, Lanzhou, 730000, China.

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

  • Source: Journal of translational medicine [J Transl Med] 2024 Aug 09; Vol. 22 (1), pp. 751. Date of Electronic Publication: 2024 Aug 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Anti-CTLA-4 treatment suppresses hepatocellular carcinoma growth through Th1-mediated cell cycle arrest and apoptosis.

  • Authors : Morihara H; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., Osaka, Japan.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: PloS one [PLoS One] 2024 Aug 06; Vol. 19 (8), pp. e0305984. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Cytotoxic T-lymphocyte-associated 4 protein expression is associated with a high international prognostic score in advanced-stage classical Hodgkin lymphoma.

  • Authors : Pangaribuan FD; Anatomical Pathology Department, Persahabatan Hospital, Jakarta, 13230, Indonesia.; Ham MF

Subjects: Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/pathology ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/metabolism ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/immunology

  • Source: BMC research notes [BMC Res Notes] 2024 Jul 08; Vol. 17 (1), pp. 190. Date of Electronic Publication: 2024 Jul 08.Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-0500

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer.

  • Authors : Cheng W; Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.; Kang K

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/antagonists & inhibitors ; CTLA-4 Antigen*/CTLA-4 Antigen*/CTLA-4 Antigen*/antagonists & inhibitors ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2024 Jul 27; Vol. 17 (1), pp. 54. Date of Electronic Publication: 2024 Jul 27.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Histone acetylation risk model predicts prognosis and guides therapy selection in glioblastoma: implications for chemotherapy and anti-CTLA-4 immunotherapy.

  • Authors : Jin X; Neurosurgery Department, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.; Qin Z

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/immunology ; Glioblastoma*/Glioblastoma*/Glioblastoma*/therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy

  • Source: BMC immunology [BMC Immunol] 2024 Jul 27; Vol. 25 (1), pp. 51. Date of Electronic Publication: 2024 Jul 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

CCR5 Δ32 and CTLA-4 +49 A/G Gene Polymorphisms and Interferon-β Treatment Response in Croatian and Slovenian Multiple Sclerosis Patients.

Subjects: CTLA-4 Antigen*/CTLA-4 Antigen*/CTLA-4 Antigen*/genetics ; Receptors, CCR5*/Receptors, CCR5*/Receptors, CCR5*/genetics ; Interferon-beta*/Interferon-beta*/Interferon-beta*/therapeutic use

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 05; Vol. 25 (13). Date of Electronic Publication: 2024 Jul 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Association of tuberculosis risk with genetic polymorphisms of the immune checkpoint genes PDCD1, CTLA-4, and TIM3.

  • Authors : Liu CW; Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.; Translational Medicine Center, Taoyuan General Hospital, Department of Health and Welfare, Taoyuan, Taiwan.

Subjects: CTLA-4 Antigen*/CTLA-4 Antigen*/CTLA-4 Antigen*/genetics ; Genetic Predisposition to Disease* ; Hepatitis A Virus Cellular Receptor 2*/Hepatitis A Virus Cellular Receptor 2*/Hepatitis A Virus Cellular Receptor 2*/genetics

  • Source: PloS one [PLoS One] 2024 May 09; Vol. 19 (5), pp. e0303431. Date of Electronic Publication: 2024 May 09 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer.

  • Authors : Shin DS; Department of Medicine, Division of Hematology-Oncology, VAGLAHS/David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California, USA.; Basak S

Subjects: CTLA-4 Antigen*/CTLA-4 Antigen*/CTLA-4 Antigen*/antagonists & inhibitors ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/pharmacology ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use

  • Source: Cancer medicine [Cancer Med] 2024 May; Vol. 13 (9), pp. e7212.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors.

  • Authors : Zhao Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, No. 651 Dongfeng East Road, Guangzhou, 510060, China.; Ma Y

Subjects: Antibodies, Bispecific* ; Antineoplastic Agents* ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2023 May 08; Vol. 16 (1), pp. 50. Date of Electronic Publication: 2023 May 08.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  2,553 نتائج ل ""CTLA-4 Antigen""